Guillain-Barré Syndrome in a Crohn`s Disease Patient Treated With Vedolizumab

J Crohns Colitis. 2020 Dec 2;14(12):1788-1789. doi: 10.1093/ecco-jcc/jjaa101.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Crohn Disease / drug therapy*
  • Diagnosis, Differential
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / therapeutic use*
  • Guillain-Barre Syndrome / chemically induced
  • Guillain-Barre Syndrome / diagnosis*
  • Humans
  • Male

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab